If you're a trend trader, consider that the strongest clear trend on the daily chart exists on the 100 day timeframe.The post BioNTech SE (BNTX): Price Up $8.54 (3.48)% Over Past...
By Dhirendra TripathiInvesting.com – Shares of vaccine makers rose Tuesday after Fox News anchors endorsed vaccinations amid a growing outbreak of coronavirus infections connected...
By Geoffrey Smith Investing.com -- U.S. stock markets opened modestly higher on Tuesday, but another sign of the housing market weakening took much of the energy out of an...
The first week of earnings season wraps up with major indices closely tracking the bond market in Wall Street’s version of “follow the leader.” Earnings...
BioMarin Pharmaceutical (NASDAQ:BMRN) Inc. BMRN announced that it has received positive recommendation from European Medicines Agency's Committee for Medicinal Products for Human...
Axsome Therapeutics (NASDAQ:AXSM), Inc. AXSM announced that it plans to submit a new drug application (NDA) for its pipeline candidate, AXS-14, in the fourth quarter of 2022. The...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Sell | Strong Buy | Strong Buy | Strong Buy | Buy |
| Summary | Neutral | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,660.30 | 2,668.00 | 2,596.00 | +91.9 | +3.58% | 2.08M | ||||
| 369.79 | 375.33 | 357.19 | +18.60 | +5.30% | 33.69M | NASDAQ | |||
| 27.23 | 28.17 | 26.93 | -1.33 | -4.66% | 10.98M | NASDAQ | |||
| 17.61 | 27.00 | 13.85 | -10.36 | -37.04% | 7.76M | NASDAQ | |||
| 13.06 | 13.21 | 12.82 | -0.10 | -0.76% | 1.04M | ||||
| 31.49 | 31.55 | 30.90 | +0.65 | +2.11% | 135.97K | NASDAQ | |||
| 30.35 | 30.39 | 30.00 | +0.49 | +1.64% | 782.96K | NYSE | |||
| 11.32 | 11.92 | 11.21 | -0.81 | -6.68% | 14.00M | NASDAQ | |||
| 26.97 | 27.25 | 26.72 | -0.05 | -0.18% | 71.76K | NASDAQ | |||
| 2.12 | 2.275 | 2.09 | -0.040 | -1.85% | 697.00K | NASDAQ | |||
| 16.67 | 16.81 | 16.55 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 85.48 | 85.60 | 83.17 | +2.34 | +2.81% | 2.72M | NASDAQ | |||
| 163.55 | 163.84 | 161.67 | +1.53 | +0.94% | 2.18M | NASDAQ | |||
| 17.06 | 17.32 | 16.63 | -0.97 | -5.38% | 10.25M | NYSE | |||
| 97.31 | 100.58 | 95.97 | -7.65 | -7.29% | 11.85M | NASDAQ |
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
